Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Tumor-Agnostic 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 117Colonic Neoplasms 30Rectal Neoplasms 27Neoplasms 20Neoplasm Metastasis 19Esophageal Neoplasms 10Pancreatic Neoplasms 9Cholangiocarcinoma 7Colorectal Cancer Metastatic 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Gastrointestinal Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Stomach Neoplasms 2Prostatic Neoplasms 2Biliary Tract Neoplasms 2Thyroid Neoplasms 1Recurrence 1Pancreatic Adenocarcinoma 1Oesophago-gastric Cancer 1Neoplasms, Second Primary 1Kidney Neoplasms 1KRAS and NRAS Wild-type Colorectal Cancer 1Histiocytosis 1Gallbladder Neoplasms 1Exanthema 1Esophageal Squamous Cell Carcinoma 1Elderly Metastatic Colorectal Cancer Patients 1Dihydropyrimidine Dehydrogenase Deficiency 1

Interventions

Paclitaxel 11Fluorouracil 10pembrolizumab 9Cisplatin 9Radiotherapy 7Carboplatin 6Esophagectomy 5Nivolumab 4Drug Therapy 4Radiotherapy, Intensity-Modulated 3Leucovorin 3Chemoradiotherapy 3Cetuximab 3Capecitabine 3durvalumab 2atezolizumab 2Oxaliplatin 2Ipilimumab 2spartalizumab 1sintilimab 1selinexor 1regorafenib 1prexasertib 1osimertinib 1niraparib 1nilotinib 1nedaplatin 1nanocis 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Panitumumab × Gastrointestinal × Clear all
NCT01077999 2021-04-21

Chemoradiation and Panitumumab for Esophageal Cancer

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed
78 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡